海外の治験の状況「%E8%84%B3%E5%8D%92%E4%B8%AD」での検索結果
261件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 国名
- 登録日
Not Recruiting
- A multi-center, open label, single-arm study to investigate the safety and efficacy of daily oral administration of 2 mg dienogest tablets for the treatment of endometriosis in adolescents over a treatment period of 52 weeks
- Endometriosis MedDRA version: 15.0 Level: PT Classification code 10014778 Term: Endometriosis System Organ Class: 10038604 - Reproductive system and breast disorders ;Therapeutic area: Diseases [C] - Female diseases of the urinary and reproductive systems and pregancy complications [C13]
- Austria, Czech Republic, Finland, Germany, Spain
- 2010-11-16
Not recruiting
- A Study to Assess the Efficacy and Safety of Dupilumab in Patients With Severe Atopic Dermatitis (AD) That Are Not Controlled With Oral Cyclosporine A (CSA) or for Those Who Cannot Take Oral CSA Because it is Not Medically Advisable
- Atopic Dermatitis;Atopic Dermatitis;Atopic Dermatitis;Atopic Dermatitis
- Austria, Belgium, Germany, Ireland, Netherlands, Poland, Russian Federation, Slovakia, Spain, United Kingdom
- 2016-03-02
Not recruiting
- CREAD Study: A Study of Crenezumab Versus Placebo to Evaluate the Efficacy and Safety in Participants With Prodromal to Mild Alzheimer's Disease (AD)
- Alzheimer's Disease
- Australia, Austria, Belgium, Bulgaria, Canada, Costa Rica, Croatia, Czech Republic, Czechia, Denmark, Finland, France, Germany, Hong Kong, Hungary, Italy, Japan, Korea, Republic of, Lithuania, Mexico, Poland, Portugal, Russian Federation, Slovenia, Spain, Sweden, Switzerland, Turkey, Ukraine, United Kingdom, United States
- 2016-01-28
Authorised
- A Safety and Efficacy Study for Alzheimer's Disease (Prodromal AD)
- prodromal Alzheimer's Disease MedDRA version: 16.0 Level: HLT Classification code 10001897 Term: Alzheimer's disease (incl subtypes) System Organ Class: 100000004852 ;Therapeutic area: Diseases [C] - Nervous System Diseases [C10]
- Argentina, Australia, Austria, Belgium, Brazil, Canada, Czech Republic, Finland, France, Germany, Italy, Japan, Netherlands, New Zealand, Norway, South Africa, Spain, Switzerland, United Kingdom, United States
- 2013-09-17
Not recruiting
- Efficacy of Alogliptin With Pioglitazone (Actos®) in Subjects With Type 2 Diabetes Mellitus
- Diabetes Mellitus;Diabetes Mellitus;Diabetes Mellitus;Diabetes Mellitus
- Argentina, Australia, Brazil, Bulgaria, Chile, Croatia, Estonia, Former Serbia and Montenegro, Guatemala, Hungary, India, Israel, Latvia, Lithuania, Mexico, New Zealand, Peru, Poland, Romania, Russian Federation, Serbia, Slovakia, South Africa, Ukraine, United States
- 2006-11-01
Not Recruiting
- Multi center, double blind, randomized, placebo controlled, active reference, parallel group polysomnography study to assess the efficacy and safety of a 16 day oral administration of ACT 078573 in adult subjects with chronic primary insomnia.
- Chronic primary insomnia MedDRA version: 9.1 Level: LLT Classification code 10022437 Term: Insomnia
- Austria, Belgium, Bulgaria, Czech Republic, Denmark, Finland, France, Germany, Hungary, Italy, Slovakia, Spain, Sweden, United Kingdom
- 2008-05-06
Not recruiting
- A Post-marketing Observational Study Of The Use Of Zonisamide (ZNS) in the Adjunctive Treatment Of Adult Patients With Partial Onset Seizures (Study E2090-E044-410) (ZOOM)
- Partial Onset Seizures
- Austria, Denmark, Germany, Norway, Sweden
- 2013-04-10
Not Recruiting
- A study to assess the efficacy and safety of Dupilumab in patients with severe atopic dermatitis (AD) that are not controlled with oral cyclosporine A (CSA) or for those who cannot take oral CSA because it is not medically advisable
- Atopic dermatitis MedDRA version: 19.0 Level: LLT Classification code 10003639 Term: Atopic dermatitis System Organ Class: 100000004858 ;Therapeutic area: Diseases [C] - Skin and Connective Tissue Diseases [C17]
- Austria, Belgium, France, Germany, Ireland, Italy, Netherlands, Poland, Russian Federation, Slovakia, Spain, United Kingdom
- 2015-09-24
Recruiting
- An Extension Study of ABBV-8E12 in Early Alzheimer's Disease (AD)
- Alzheimer's Disease
- Australia, Belgium, Canada, Finland, Italy, New Zealand, Spain, United States
- 2018-10-18
Authorised
- A study to help understand how Baricitinib in Combination with Topical Corticosteroids compares to placebo (a tablet that does not contain any active medicine) in patients with moderate to severe atopic dermatitis, also named atopic eczema
- Atopic Dermatitis MedDRA version: 20.0 Level: LLT Classification code 10003639 Term: Atopic dermatitis System Organ Class: 100000004858 ;Therapeutic area: Diseases [C] - Skin and Connective Tissue Diseases [C17]
- Argentina, Australia, Austria, Germany, Italy, Japan, Korea, Republic of, Poland, Spain, Taiwan
- 2018-09-26